Pharming Group Competitors and Similar CompaniesClear all
Ambrx's competitors and similar companies include Strategic Partners.
 Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. |  Strategic Partners Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies. | |
Founding Date | Founding Date 2003 | Founding Date 2009 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations København, DK HQ Chicago, US Newton, US |
Employees | Employees 70 | Employees 1 |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 6.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $7.4m (FY, 2022) | Revenue (est.) kr309k (FY, 2025) |
Net income | Net income ($78m) (FY, 2022) | Net income (kr859k) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 347.9m | Total funding raised $ 58.8m |
For sources of this data, please see the company profile
View Company Profiles
Strategic Partners
HQ
København, DK
Employees
1
Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies.
View company